InvestorsHub Logo
Followers 91
Posts 5592
Boards Moderated 0
Alias Born 06/05/2008

Re: None

Friday, 06/29/2018 12:56:20 AM

Friday, June 29, 2018 12:56:20 AM

Post# of 8169
More news; more price loses

On June 28, 2018, we issued a press release announcing that we will expand patient enrollment in the diffuse large b-cell lymphoma (DLBCL) cohort of our currently enrolling Phase 2 clinical trial of CLR 131. A copy of the press release is furnished as Exhibit 99.1 and is incorporated by reference herein.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CLRB News